Tuesday, August 25, 2026

Tesla Stock Jumped 3.55% on Wednesday: Will it Correct on The Next Session?

ViaNews Editorial Team

November 26, 2020

Tesla Stock Jumped 3.55% on  Wednesday: Will it Correct on The Next Session?
Tesla shares jumped 3.35% to $574.00 at yesterday, The Nasdaq Stock Market is rose 0.48% to $12,094.40. According to tuesday's article on Bloomberg Quint, "Nikola, Tesla Shares Fall as EV Rally Frenzy Comes to a Halt." According to Tuesday's article on MarketWatch, "Tesla issues recall of 9,000-plus Model X and Model Y vehicles." Tesla's last close was $555.38, 0.05% under its 52-week high of $573.70. Tesla's sales growth is 35.3% for the ongoing quarter and 60% for the next. The company's growth estimates for the ongoing quarter and the next is 112.2% and 265.2%, respectively. Year-on-year quarterly revenue growth grew by 39.2%, now sitting on 28.18B for the twelve trailing months. Tesla's stock is valued at $574.00 at 08:26 EST, above its 52-week high of $573.70. Tesla's worth is way higher than its 50-day moving average of $435.96 and way higher than its 200-day moving average of $332.14. Tesla-heavy etfs ride along as company gets a price upgrade. According to MarketWatch on Mon Nov 23, "Exchovere-traded funds with heavy exposure to Tesla Inc." According to Bloomberg Quint on Tue Nov 24, "Musk Hints Again at Longer-Range Teslas and Hatchback for Europe." According to Bloomberg Quint on Tue Nov 24, "Tesla Nears Half a Trillion Mark After Soaring 525% This Year."
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com